Synthetic Genomics and ExxonMobil Renew Algae Biofuels Research Agreement

Renewal continues fundamental research into advanced biofuels Large team of researchers focused on Synthetic Genomics’ core synthetic biology technologies Progress continues toward development of algae-based transportation fuels LA JOLLA, Calif.----Synthetic Genomics, Inc. and ExxonMobil (NYSE: XOM) announced today that they have extended their agreement to conduct joint research into advanced algae biofuels after making significant [...]

Protea Extends Collaboration with Protein Metrics

MORGANTOWN, W.Va. -- Protea Biosciences Group, Inc. (OTCQB:PRGB) (“Protea”) announced today that the Company has signed a renewal of its collaboration with California-based Protein Metrics Inc. for further applications development of their advanced analytical software for Protea’s molecular information services. “By combining our high-resolution mass spectrometry molecular data with the analytical power of Protein Metrics software, [...]

908 Devices Strengthens Life Science Leadership Team and Unveils Transformational Advancements to ZipChip

908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecule analysis, today announced significant product enhancements for ZipChip™, an innovative system that provides high-quality separation capabilities as a front-end for mass spectrometry (MS). An integrated autosampler, built-in chip recognition intelligence and application specific assay kits are being released to radically improve process efficiencies for [...]

VUV Analytics Hires New Senior Director of Applications

Addition to Executive Team Expands Company's Chromatography and Applications Expertise Austin, TX - VUV Analytics Inc. is pleased to announce Jack Cochran as Senior Director of Applications. "Applications development is becoming increasingly important, as VUV technology proliferates from R&D chemists and early adopters to mainstream analytical users across the full range of laboratory and process functions, " said [...]

SEVEN BRIDGES PLATFORM GOES GLOBAL: NOW LIVE ON AWS EU (FRANKFURT) REGION

Provides Fast, Easy Way for Seven Bridges Users to Access and Analyze Data Generated in Europe, under the Protection of EU Data Protection Regulations CAMBRIDGE, Mass. – Seven Bridges, the biomedical data analysis company, today announced that the Seven Bridges Platform is now live on the Amazon Web Services (AWS) EU (Frankfurt) Region in Frankfurt, Germany, [...]

Synthomics Announces Completion Of Seed Financing And Launch Of Early Access Program For Next-generation DNA Synthesis Platform

MENLO PARK, Calif. -- Synthomics, Inc., an emerging developer of next-generation systems for oligonucleotide synthesis, announced today that it has completed seed round financing and has launched an early access program for its end-to-end DNA synthesis platform. The financing round was anchored by TEEC Angel Fund (https://www.teec-angel.com), a Palo Alto, CA-based Micro VC fund with an [...]

Sartorius Stedim Biotech supports mainstream adoption of Quality by Design

Unique technology portfolio enables design space characterization, effective translation to the large-scale and enhanced process analytics Goettingen, Germany / Aubagne, France --Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has developed an innovative and fully integrated technology platform to meet the requirements of today’s upstream bioprocessing. It will allow customers to adopt [...]

Leistungselektronik JENA GmbH signs license agreement with Carl Zeiss Microscopy GmbH

Leistungselektronik JENA GmbH (LEJ) is proud to announce the signing of a license agreement with Carl Zeiss Microscopy GmbH. LEJ received a license to the patents US 6154282 A and CA 2280398 C relating to LED fluorescence excitation in microscopy. The license covers LEJ’s comprehensive range of LED fluorescence excitation solutions to be sold in [...]

PharmaFluidics raises 2.7 million euro to commercialize novel micro-chip device for Biomarker, Diagnostics and Drug development applications

Ghent, Belgium PharmaFluidics NV, a game-changing innovator in the field of analytical chromatography, announced today that it has raised 2.7 million euro of additional funding. The funding was subscribed by a consortium of PharmaFluidics’ existing shareholders, new investors and management. Shareholders include Qbic Arkiv Fund, the Flemish investment company PMV, Theodorus Fund, Innovation Fund and [...]

Roka Bioscience Announces Transition of CEO Role from Paul Thomas to Mary Duseau

WARREN, N.J. -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens today announced the appointment of Mary Duseau as President and CEO.  Ms. Duseau succeeds Paul Thomas, the Company's President and CEO since 2009, who will assume the position as Chairman of the [...]

Access IBO on Knowledge Center